Jacob Chacko, President and CEO at Oric Pharmaceuticals, Inc. (ORIC), sold 29,078 shares at $8.58 ($249K) on 2023-12-15, disclosed to the SEC on 2023-12-19.
Open-market sale of $249k ORIC by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $8.58 | 14,539 | $125K | 50.0% |
| 2 | $8.58 | 14,539 | $125K | 50.0% |
| Total | $8.58 avg | 29,078 | $249K | 100% |
| Filing → |
| ORIC | SELL | 2025-10-02 | $2.1M | — | Filing → |
| ORIC | SELL | 2025-09-24 | $1.4M | — | Filing → |
| ORIC | SELL | 2024-12-17 | $408K | — | Filing → |